| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Mar 07, 2013 |
|||||||||
| Q4 FY13 | $0.44 | $0.35 | $24.15B | $24.12B |
NYSE |
||||
|
Delek US Holdings
DK
|
Q4 FY12 | $1.06 | $1.00 | $2.18B | - |
NYSE |
|||
|
Thor Industries
THO
|
- | $0.37 | $0.38 | $741.60M | $653.81M |
NYSE |
|||
|
Ciena Corporation
CIEN
|
Q1 FY13 | $0.12 | -$0.13 | $453.09M | $490.86M |
NYSE |
|||
|
John Wiley & Sons
WLY
|
Q3 FY13 | $0.93 | $0.83 | $445.85M | - |
NYSE |
|||
|
Nexstar Media Group
NXST
|
Q4 FY12 | $0.20 | $0.47 | $116.17M | $433.81M |
NASDAQ |
|||
|
Primoris Services
PRIM
|
Q4 FY12 | $0.33 | $0.29 | $480.88M | $422.61M |
NYSE |
|||
|
The Cooper Companies
COO
|
Q1 FY13 | $0.31 | $0.30 | $379.84M | $367.45M |
NASDAQ |
|||
|
IDT
IDT
|
Q2 FY13 | $0.13 | $0.30 | $411.69M | $301.10M |
NYSE |
|||
|
Consolidated Communications
CNSL
|
Q4 FY12 | $0.20 | $0.17 | $160.08M | $145.26M |
NASDAQ |
|||
|
National Beverage
FIZZ
|
- | $0.09 | - | $144.72M | - |
NASDAQ |
|||
| Q4 FY13 | -$0.16 | -$0.21 | $81.52M | $106.99M |
NASDAQ |
||||
|
Emergent BioSolutions
EBS
|
Q4 FY12 | $0.44 | $0.45 | $94.61M | $96.75M |
NYSE |
|||
|
Chesapeake Utilities
CPK
|
- | $0.68 | $0.58 | $109.52M | $93.40M |
NYSE |
|||
|
Apple Hospitality REIT
APLE
|
- | $0.14 | - | $86.73M | - |
NYSE |
|||
|
Medifast
MED
|
Q4 FY12 | $0.28 | $0.25 | $83.24M | $74.29M |
NYSE |
|||
|
U.S. Physical Therapy
USPH
|
Q4 FY12 | $0.34 | $0.33 | $62.69M | $60.56M |
NYSE |
|||
|
Comtech Telecommunications
CMTL
|
- | $0.14 | $0.11 | $74.58M | $58.61M |
NASDAQ |
|||
|
Information Services Group
III
|
- | - | - | $49.52M | - |
NASDAQ |
|||
|
Saul Centers
BFS
|
- | $0.54 | $0.61 | $48.29M | - |
NYSE |
|||
|
Quanex Building Products
NX
|
Q1 FY13 | -$0.17 | -$0.07 | $185.71M | $43.69M |
NYSE |
|||
|
H&R Block
HRB
|
Q3 FY13 | -$0.22 | -$0.03 | $471.98M | $42.91M |
NYSE |
|||
|
CECO Environmental
CECO
|
Q4 FY12 | $0.18 | $0.18 | $34.33M | - |
NASDAQ |
|||
|
Middlesex Water
MSEX
|
- | $0.17 | $0.18 | $27.08M | $28.67M |
NASDAQ |
|||
|
Identiv
INVE
|
Q4 FY12 | $0.10 | -$0.40 | $26.59M | - |
NASDAQ |
|||
|
Cohen &
COHN
|
- | $1.79 | - | $23.38M | - |
AMEX |
|||
|
Main Street Capital
MAIN
|
- | $0.56 | $0.49 | $30.93M | $22.90M |
NYSE |
|||
|
Ambarella
AMBA
|
Q4 FY13 | $0.18 | $0.13 | $31.52M | $22.75M |
NASDAQ |
|||
|
Plus Therapeutics
PSTV
|
Q4 FY12 | -$4.50 | -$11.63 | $7.33M | $18.94M |
NASDAQ |
|||
|
Repligen
RGEN
|
Q4 FY12 | $0.31 | $0.07 | $18.81M | - |
NASDAQ |
|||
|
First Mid Bancshares
FMBH
|
- | $0.59 | - | $18.74M | - |
NASDAQ |
|||
|
BlackRock TCP Capital
TCPC
|
- | $0.59 | $0.44 | $17.18M | $13.39M |
NASDAQ |
|||
|
Fidus Investment
FDUS
|
- | $0.40 | $0.38 | $9.64M | $9.16M |
NASDAQ |
|||
|
Pacira BioSciences
PCRX
|
Q4 FY12 | -$0.50 | -$0.41 | $10.45M | $8.78M |
NASDAQ |
|||
|
Phillips Edison & Co
PECO
|
- | -$0.33 | - | $7.08M | - |
NASDAQ |
|||
|
MiMedx Group
MDXG
|
Q4 FY12 | -$0.01 | -$0.01 | $10.51M | $5.26M |
NASDAQ |
|||
|
ClearPoint Neuro
CLPT
|
Q4 FY12 | -$0.40 | -$0.80 | $1.86M | $3.73M |
NASDAQ |
|||
|
Celldex Therapeutics
CLDX
|
Q4 FY12 | -$4.05 | -$3.75 | $3.65M | $3.38M |
NASDAQ |
|||
|
Dyadic International
DYAI
|
Q4 FY12 | -$0.04 | - | $2.71M | - |
NASDAQ |
|||
|
Corcept Therapeutics
CORT
|
- | -$0.09 | -$0.09 | $1.38M | $1.13M |
NASDAQ |
|||
|
Sarepta Therapeutics
SRPT
|
Q4 FY12 | -$0.39 | -$0.38 | $7.34M | $901.95K |
NASDAQ |
|||
|
Cosmos Health
COSM
|
- | -$1.15 | - | - | - |
NASDAQ |
|||
| Show 32 more companies | |||||||||
